BackDicerna Pharmaceuticals Overview

Dicerna Pharmaceuticals Current Cash

Dicerna Pharmaceuticals's current cash is $170M.

Get informed when a big investor buys or sells

+ Follow
Current Cash
$165.76M
↓ 18.86% YoYΔ $-38.52M vs prior year quarter

Peer trimmed avg / median

Loading

Dicerna Pharmaceuticals Current Cash History

Loading

Dicerna Pharmaceuticals vs. peers: Current Cash Comparison

Loading

Dicerna Pharmaceuticals Cash Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Dicerna Pharmaceuticals (DRNA) FAQ

As of the most recent data (September 2021), DRNA shows a current cash of $170M. That compares with $200M in the prior-year period — down 18.9% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, DRNA's current cash is now $170M (was $200M) — a 18.9% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Dicerna Pharmaceuticals is outperforming or lagging.

Tracking DRNA's current cash over time shows whether Dicerna Pharmaceuticals is scaling, shrinking, or reshaping that part of the business. The current reading is $170M That compares with $200M in the prior-year period — down 18.9% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current cash page, Stockcircle has Dicerna Pharmaceuticals's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current cash (currently $170M) with ownership activity and broader fundamentals.

Dicerna Pharmaceuticals's current cash is $170M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.